Experimental & Molecular Medicine,
Год журнала:
2025,
Номер
unknown
Опубликована: Май 1, 2025
The
search
for
more
effective
and
safer
cancer
therapies
has
led
to
an
increasing
interest
in
combination
treatments
that
use
well-established
agents.
Here
we
explore
the
potential
of
cannabidiol
(CBD),
a
compound
derived
from
cannabis,
enhance
anticancer
effects
etoposide
non-small
cell
lung
(NSCLC).
Although
CBD
is
primarily
used
manage
childhood
epilepsy,
its
broader
therapeutic
applications
are
being
actively
investigated,
particularly
oncology.
Our
results
revealed
that,
among
various
tested
chemotherapeutic
drugs,
showed
most
significant
reduction
NSCLC
viability
when
combined
with
CBD.
To
understand
this
synergistic
effect,
conducted
extensive
transcriptomic
proteomic
profiling,
which
upregulated
genes
associated
autophagic
death
while
downregulating
key
oncogenes
known
drive
tumor
progression.
This
dual
effect
on
oncogene
suppression
was
mediated
by
inactivation
PI3K-AKT-mTOR
signaling
pathway,
crucial
regulator
growth
survival,
found
be
dependent
p53
status.
Interestingly,
our
analysis
therapy
did
not
rely
traditional
cannabinoid
receptors
or
transient
receptor
cation
channels,
indicating
exerts
through
novel,
noncanonical
mechanisms.
findings
suggest
could
represent
groundbreaking
approach
treatment,
cases
where
conventional
fail.
By
inducing
inhibiting
oncogenic
pathways,
strategy
offers
promising
new
avenue
enhancing
treatment
efficacy
NSCLC,
especially
tumors
function.
Pharmaceutical Biology,
Год журнала:
2025,
Номер
63(1), С. 229 - 249
Опубликована: Апрель 15, 2025
Total
flavonoids
from
Litchi
chinensis
Sonn.
(Sapindaceae)
seeds
(TFLS)
effectively
attenuate
stem
cell-like
properties
in
breast
cancer
cells.
However,
their
pharmacological
effects
and
mechanisms
suppressing
metastasis
remain
unclear.
This
study
aimed
to
elucidate
the
inhibitory
underlying
of
TFLS
on
metastasis.
The
antiproliferative,
migratory,
invasive
activities
cells
following
treatment
were
evaluated
using
CCK-8,
wound-healing,
transwell
assays.
epithelial-mesenchymal
transition
(EMT)
biomarkers
via
Western
blot
analysis.
anti-metastatic
further
validated
vivo
zebrafish
mouse
models.
Network
pharmacology
methodology
was
utilized
predict
potential
targets
signaling
pathways,
which
subsequently
corroborated
by
blot.
Potential
active
compounds
identified
through
molecular
docking,
chemical
constituents
analyzed
characterized
UPLC-QTOF/MS.
suppressed
proliferation
MDA-MB-231
MDA-MB-468
cells,
with
IC50
values
44.47
μg/mL
37.35
at
72
h,
respectively.
It
vitro,
demonstrated
a
marked
reduction
cellular
motility
invasiveness,
alongside
reversal
EMT.
Consistent
pathway
enrichment
analysis,
network
revealed
that
reduced
phosphorylation
levels
PI3K,
AKT,
mTOR,
JNK,
ERK,
p38
Molecular
docking
seven
ingredients,
UPLC-MS/MS
confirmed
presence
key
compounds,
including
procyanidin
A2.
inhibits
cell
proliferation,
migration,
invasion
vitro
reversing
EMT
phenotype,
while
vivo.
These
are
likely
mediated
attenuation
PI3K/AKT/mTOR
MAPK
pathways.
Biomedicines,
Год журнала:
2025,
Номер
13(4), С. 990 - 990
Опубликована: Апрель 18, 2025
Estrogen
receptors
(ERs)
play
a
critical
role
in
breast
cancer
(BC)
development
and
progression,
with
ERα
being
oncogenic
ERβ
exhibiting
tumor-suppressive
properties.
The
interaction
between
ER
signaling
other
molecular
pathways,
such
as
PI3K/AKT/mTOR,
influences
tumor
growth
endocrine
resistance.
Emerging
research
highlights
the
of
prebiotics
modulating
gut
microbiota,
which
may
influence
estrogen
metabolism,
immune
function,
therapeutic
responses
BC.
This
review
explores
impact
on
receptor
modulation,
microbiota
composition,
regulation,
metabolic
pathways
cancer.
potential
adjunctive
therapies
to
enhance
treatment
efficacy
mitigate
chemotherapy-related
side
effects
is
discussed.
A
comprehensive
analysis
recent
preclinical
clinical
studies
was
conducted,
examining
reprogramming
short-chain
fatty
acids
(SCFAs)
derived
from
prebiotic
fermentation
epigenetic
regulation
resistance
also
evaluated.
Prebiotics
were
found
modulate
microbiota-estrogen
axis,
reduce
inflammation,
responses.
SCFAs
demonstrated
selective
downregulation
reprogramming,
suppressing
growth.
Synbiotic
interventions
effects,
improving
quality
life
patients.
offer
promising
avenue
for
prevention
therapy
by
pathways.
Future
trials
are
needed
validate
their
treatments
management.
Nutrients,
Год журнала:
2025,
Номер
17(9), С. 1404 - 1404
Опубликована: Апрель 22, 2025
Background/Objectives:
High-intensity
interval
training
(HIIT)
and
time-restricted
feeding
(TRF)
have
shown
potential
in
enhancing
glucose
metabolism,
increasing
insulin
sensitivity,
promoting
muscle
health.
This
study
investigates
the
combined
effects
of
HIIT
TRF
on
AKT-IGF-1-mTOR
signaling
pathway
tissue
type
2
diabetic
(T2D)
rats.
Methods:
42
male
Wistar
rats
(4–5
weeks
age)
were
included
study.
The
animals
randomly
divided
into
two
groups:
1.
Standard
diet
(SD)
non-diabetic
(n
=
7)
2.
High-fat
(HFD
n
35)
for
4
weeks.
T2D
was
induced
by
intraperitoneal
injection
(IP)
streptozotocin
(STZ)
at
35
mg/kg.
Animals
with
blood
levels
≥
250
mg/dL
considered
diabetic.
Diabetic
five
groups
7):
Diabetes-HIIT
(D-HIIT),
Diabetes-TRF
(D-T),
3.
Diabetes-combined
(D-T+HIIT),
4.
Diabetes-Untreated
Control
(D),
5.
Diabetes
metformin
(D-MET).
protocol
regimen
followed
10
Muscle
collected
histological
analysis,
expression
proteins
related
to
measured.
Results:
Blood
levels,
resistance
(IR),
markers
degradation
significantly
improved
D-T+HIIT
D-MET
compared
non-diabetes
group.
Furthermore,
activation
AKT
mTOR
proteins,
as
well
increased
IGF-1
expression,
elevated
group
control
other
treatment
groups,
approached
observed
Additionally,
fiber
size
overall
structure
particularly
Conclusions:
combination
appears
offer
superior
benefits
improving
protein
synthesis,
regulation
rats,
either
or
alone.
These
findings
highlight
this
approach
addressing
muscle-related
complications
T2D.
Frontiers in Pharmacology,
Год журнала:
2025,
Номер
16
Опубликована: Апрель 28, 2025
To
explore
the
mechanism
of
action
baicalin
(BA)
in
treatment
triple-negative
breast
cancer
(TNBC)
based
on
network
pharmacology,
molecular
docking
and
dynamics
simulations
vitro
validation.
The
inhibitory
effects
different
concentrations
proliferation
MDA-MB-231,
4T1,
MCF-7,
MCF-10A
cell
lines
were
evaluated
by
CCK8
assay
with
clone
formation
assay.
Three
compound
target
prediction
platforms,
Swiss
Target
Prediction,
SEA
Pharmmapper,
used
to
predict
baicalin-related
targets,
mapped
cancer-related
targets
retrieved
from
GeneCards
OMMI
databases
obtain
potential
for
cancer;
STRING
database
Cytoscape
software
construct
protein
interaction
screen
core
targets;
GO
KEGG
enrichment
analyses
performed
binding
key
was
verified
simulation;
expression
relevant
proteins
verified.
Baicalin
showed
more
obvious
antiproliferative
at
certain
concentrations,
had
less
effect
normal
cells.
A
total
nine
cancer,
including
AKT1,
ESR1,
TNF-α,
SRC,
EGFR,
MMP9,
JAK2,
PPARG,
GSK3B,
identified
through
construction
PPI
interactions
'Traditional
Chinese
Medicine-Component-Target-Disease'
network,
a
252
related
intersected
analysis.
analysis
enriched
2,526
Biological
process,
105
Cellular
component
250
Molecular
function
intersecting
128
signaling
pathways
results
studies
found
that
able
interact
other
breast,
JAK2
proteins,
significant
changes
levels
proteins.
inhibits
TNF-α
their
cancer.
Experimental & Molecular Medicine,
Год журнала:
2025,
Номер
unknown
Опубликована: Май 1, 2025
The
search
for
more
effective
and
safer
cancer
therapies
has
led
to
an
increasing
interest
in
combination
treatments
that
use
well-established
agents.
Here
we
explore
the
potential
of
cannabidiol
(CBD),
a
compound
derived
from
cannabis,
enhance
anticancer
effects
etoposide
non-small
cell
lung
(NSCLC).
Although
CBD
is
primarily
used
manage
childhood
epilepsy,
its
broader
therapeutic
applications
are
being
actively
investigated,
particularly
oncology.
Our
results
revealed
that,
among
various
tested
chemotherapeutic
drugs,
showed
most
significant
reduction
NSCLC
viability
when
combined
with
CBD.
To
understand
this
synergistic
effect,
conducted
extensive
transcriptomic
proteomic
profiling,
which
upregulated
genes
associated
autophagic
death
while
downregulating
key
oncogenes
known
drive
tumor
progression.
This
dual
effect
on
oncogene
suppression
was
mediated
by
inactivation
PI3K-AKT-mTOR
signaling
pathway,
crucial
regulator
growth
survival,
found
be
dependent
p53
status.
Interestingly,
our
analysis
therapy
did
not
rely
traditional
cannabinoid
receptors
or
transient
receptor
cation
channels,
indicating
exerts
through
novel,
noncanonical
mechanisms.
findings
suggest
could
represent
groundbreaking
approach
treatment,
cases
where
conventional
fail.
By
inducing
inhibiting
oncogenic
pathways,
strategy
offers
promising
new
avenue
enhancing
treatment
efficacy
NSCLC,
especially
tumors
function.